Paid Clinical Trials and Focus Groups by Category |
|
|
|
Conditions: Breast Cancer; Gynecologic Cancer
Intervention:
Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting - verified March 2010
Conditions: Prostate Cancer; Erectile Dysfunction
Intervention: Biological: injection of bone marrow mononucleated cells
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Not yet recruiting - verified March 2010
Condition: Multiple Sclerosis, Relapsing Remitting
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: HIV Infection
Intervention: Drug: Telmisartan
Sponsors: University of California, Los Angeles; California HIV/AIDS Research Program
Not yet recruiting - verified March 2010
Condition: Polycystic Ovary Syndrome
Intervention: Behavioral: Nutrition Education, Dietary Counseling, and Cooking
Sponsors: Children's Hospital Boston; Thrasher Research Fund
Not yet recruiting - verified March 2010
Conditions: Type 2 Diabetes; Hypogonadism
Intervention: Drug: Testosterone
Sponsor: Tameside Hospital NHS Foundation Trust
Not yet recruiting - verified November 2008
Conditions: Erectile Dysfunction; Arterial Hypertension; Endothelial Dysfunction
Intervention: Drug: Vardenafil
Sponsor: Hospital Universitario Pedro Ernesto
Recruiting - verified January 2010
Conditions: HIV; HIV Infections
Intervention:
Sponsor: George Washington University
Recruiting - verified March 2010
Condition: Human Immunodeficiency Virus
Intervention:
Sponsor: Abbott
Recruiting - verified February 2010
Conditions: Alcohol Dependence; Problematic Drinking; Hazardous Drinking; Human Immunodeficiency Virus; Acquired Immunodeficiency Syndrome
Interventions: Drug: Vivitrol- Intramuscular naltrexone (depot-formulation); Drug: Placebo
Sponsors: Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Not yet recruiting - verified February 2010
Condition: Familial Hypercholesterolaemia
Interventions: Drug: rosuvastatin calcium; Drug: rosuvastatin calcium; Drug: rosuvastatin calcium
Sponsor: AstraZeneca
Recruiting - verified March 2010
Conditions: Cryptococcal Meningitis; HIV Infections; AIDS
Interventions: Other: Early HIV Therapy Initiation; Other: Standard HIV Therapy Initiation
Sponsors: University of Minnesota - Clinical and Translational Science Institute; Makerere University; Mbarara University of Science and Technology; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2010
Conditions: C. Trachomatis; Gonococcal Infections
Interventions: Drug: Azithromycin; Drug: Placebo; Drug: Cefixime
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2010
Condition: Nutrition Disorders
Interventions: Procedure: Access to a Computerized Clinical Decision Support System (CCDDS); Behavioral: Education of Healthcare workers; Other: Local assistance by a dietician
Sponsor: Hospices Civils de Lyon
Recruiting - verified March 2010
Condition: Human Immunodeficiency Virus
Intervention: Drug: lopinavir/ritonavir (Kaletra)
Sponsor: Abbott
Recruiting - verified February 2010
Condition: Urinary Incontinence
Intervention: Device: Athena Pelvic Muscle Trainer
Sponsor: Athena Feminine Technologies, Inc.
Recruiting - verified March 2010
Conditions: HIV; HIV Infections
Intervention: Drug: darunavir/ritonavir then atazanavir/ritonavir
Sponsor: St Stephens Aids Trust
Not yet recruiting - verified February 2010
Condition: Sexual Dysfunctions, Psychological
Interventions: Drug: Flibanserin; Drug: Placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Sexual Dysfunction, Physiological
Intervention: Drug: dapoxetine
Sponsor: Johnson & Johnson Pte Ltd
Not yet recruiting - verified February 2010
Condition: HIV Infections
Interventions: Other: Dapivirine; Other: Placebo
Sponsor: International Partnership for Microbicides, Inc.
Not yet recruiting - verified February 2010
Conditions: Medication Reconciliation; Emergency Department
Intervention: Other: Medication reconciliation completed by a RN, CPhT, or RPh
Sponsors: Wesley Medical Center; Cardinal Health Foundation
Recruiting - verified January 2010
Condition: HIV Infections
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Gilead Sciences
Not yet recruiting - verified January 2009
Condition: Heart Failure
Intervention: Drug: LMI 1195
Sponsor: Lantheus Medical Imaging
Not yet recruiting - verified March 2010
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
Sponsors: GlaxoSmithKline; Shionogi
Recruiting - verified March 2010
Condition: HIV Infection
Intervention: Biological: blood test at day one
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - verified February 2010
Conditions: Schizophrenia; Bipolar Disorder; Autistic Disorder; Attention Deficit and Disruptive Behavior Disorders
Interventions: Drug: Other atypical antipsychotic drugs; Drug: Risperidone
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified February 2010
Condition: HIV Infections
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Genital Warts; Perianal Warts
Interventions: Drug: Polyphenon E (Veregen) 15% ointment; Other: Green Tea Beverage with defined catechin content
Sponsors: MediGene; Charité Research Organisation
Recruiting - verified March 2010
Condition: Dyslipidemia
Interventions: Drug: BMS-770767; Drug: BMS-770767; Drug: BMS-770767; Drug: BMS-770767; Drug: Placebo
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified January 2010
Conditions: Healthy Volunteers; HIV Infections
Interventions: Drug: Digoxin; Drug: Digoxin; Drug: Maraviroc
Sponsor: Pfizer
Not yet recruiting - verified February 2010
Condition: HIV Infections
Interventions: Drug: DRV commercial formulation/ DRV new formulation/ rtv 100mg tab; Drug: DRV commercial formulation/ DRV new formulation/ rtv 100mg tab; Drug: DRV commercial formulation/ DRV new formulation/ rtv 100mg tab; Drug: DRV commercial formulation/ DRV new formulation/ rtv 100mg tab
Sponsor: Tibotec Pharmaceuticals, Ireland
Not yet recruiting - verified February 2010
Conditions: Sexual Dysfunctions, Psychological; Depression
Interventions: Drug: flibanserin 2; Drug: placebo; Drug: flibanserin 1
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Ovarian Cancer
Interventions: Biological: bleomycin sulfate; Drug: carboplatin; Drug: cisplatin; Drug: etoposide phosphate; Drug: paclitaxel
Sponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2010
Conditions: HIV; HIV Infections
Interventions: Behavioral: 1-sided messages; Behavioral: 2-sided messages
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH)
Recruiting - verified February 2010
Conditions: Cervical Cancers; Vulvar Cancers; Vaginal Cancers; Genital Warts; Human Papillomavirus (HPV) Infection
Interventions: Biological: V503; Biological: Comparator: Placebo to V503
Sponsor: Merck
Recruiting - verified March 2010
Condition: HIV Infections
Intervention: Drug: TMC278LA
Sponsor: St Stephens Aids Trust
Recruiting - verified March 2010
Condition: HIV Infections
Interventions: Drug: Emtricitabine (FTC); Drug: Tenofovir disoproxil fumarate (TDF); Drug: Efavirenz (EFV)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified December 2009
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR); Drug: 3-4 commercially available antiretroviral drugs
Sponsor: Myriad Pharmaceuticals
Recruiting - verified March 2010
Condition: HIV Infections
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified December 2009
Condition: Human Papillomavirus
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified March 2010
Condition: Erectile Dysfunction
Interventions: Drug: Tadalafil; Drug: Placebo
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Condition: HIV Infections
Intervention: Drug: TMC278 (Rilpivirine) LA; Placebo
Sponsor: Tibotec Pharmaceuticals, Ireland
Recruiting - verified February 2010
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761 formulation 3; Drug: GSK2248761 formulation 1; Drug: GSK2248761 reference formulation; Drug: GSK2248761 formulation 2 or 4
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Conditions: Sexual Dysfunction, Physiological; Ejaculation
Interventions: Drug: Dapoxetine hydrochloride; Other: Alternate care/non-dapoxetine hydrochloride treatment(s)
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified February 2010
Conditions: HSV Infection; HIV Infection
Interventions: Drug: acyclovir; Drug: Valacyclovir
Sponsor: University of Washington
Recruiting - verified March 2010
Condition: Premature Ejaculation
Interventions: Drug: GSK557296; Drug: GSK557296; Drug: placebo
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Sexual Dysfunctions, Psychological
Interventions: Drug: Flibanserin; Drug: Placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Sexual Dysfunctions, Psychological
Interventions: Drug: flibanserin; Drug: placebo; Drug: placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Erectile Dysfunction
Intervention: Other: delivery system
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Condition: Posttraumatic Stress Disorder (PTSD)
Interventions: Drug: orvepitant; Other: Placebo
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: HIV Infections
Interventions: Drug: Darunavir/ritonavir; Drug: Lopinavir/ritonavir
Sponsor: Germans Trias i Pujol Hospital
Recruiting - verified February 2010
Conditions: HIV Infections; Hepatitis C Virus
Interventions: Drug: Nitazoxanide (NTZ); Drug: Peginterferon alfa-2a (PEG-INF); Drug: Ribavirin (RBV)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified October 2009
Condition: HIV Infections
Intervention: Behavioral: Modified client adherence profiling and intervention tailoring (CAP-IT)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2009
Condition: HIV Infections
Interventions: Behavioral: Enhanced nursing telephone support; Behavioral: Standard care
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified October 2009
Condition: C. Trachomatis
Interventions: Drug: Azithromycin; Drug: Doxycycline
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2009
Condition: Premature Ejaculation
Interventions: Drug: Tramadol Hydrochloride; Drug: Placebo
Sponsor: Biovail Laboratories International SRL
Recruiting - verified October 2009
Condition: Premature Ejaculation
Intervention: Drug: Tramadol Hydrochloride & Placebo
Sponsor: Biovail Laboratories International SRL
Recruiting - verified September 2009
Condition: Localized Prostate Cancer
Interventions: Behavioral: PC-PEP - Prostate Cancer Patient Education Program; Behavioral: Usual care
Sponsors: Baylor College of Medicine; American Cancer Society; Michael Debakey Veterans Affairs Medical Center
Recruiting - verified March 2010
Conditions: Schizophrenia; Schizoaffective Disorder
Interventions: Drug: Amantadine Hydrochloride, USP; Drug: Amantadine Hydrochloride, USP; Drug: Placebo
Sponsors: North Suffolk Mental Health Association; Ortho-McNeil Janssen Scientific Affairs, LLC
Recruiting - verified September 2009
Conditions: Hepatitis C; HIV Infections
Interventions: Drug: telaprevir or matching placebo; Drug: telaprevir or matching placebo; Biological: peginterferon alfa-2a; Drug: ribavirin
Sponsors: Vertex Pharmaceuticals Incorporated; Tibotec Pharmaceutical Limited
Recruiting - verified March 2010
Condition: HIV Infections
Interventions: Drug: Raltegravir (RAL); Drug: Atazanavir (ATV); Drug: Ritonavir (RTV); Drug: Tenofovir (TDF); Drug: Etravirine (ETV); Drug: Darunavir (DRV); Drug: Maraviroc (MVC); Drug: Lopinavir/ritonavir (LPV/r)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2009
Conditions: HIV Infections; Acquired Immunodeficiency Syndrome
Intervention: Drug: lopinavir/ritonavir plus maraviroc
Sponsors: Rodwick, Barry M., M.D.; Abbott
Recruiting - verified February 2010
Conditions: HIV Infections; HIV-1
Intervention: Drug: Etravirine
Sponsor: Tibotec Pharmaceuticals, Ireland
Recruiting - verified February 2010
Condition: HIV Infections
Intervention:
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: HIV Infections
Intervention:
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: LY2216684
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Condition: HIV Infections
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2009
Conditions: Penile Cancer; Erectile Dysfunction; Radical Prostatectomy
Interventions: Drug: Placebo QHS and sildenafil and questionnaires; Drug: Sildenafil and questionnaire; Drug: Trimix combination (Papavarine 30mg/Phentholamine 1mg/Prostaglandin E1 10 mcgs/ml) and questionnaires
Sponsors: Memorial Sloan-Kettering Cancer Center; Pfizer
Recruiting - verified March 2010
Condition: HIV Infections
Intervention: Drug: Highly active antiretroviral therapy (HAART)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Conditions: Cervical Cancer; Therapy-related Toxicity; Vaginal Cancer
Interventions: Drug: cisplatin; Drug: triapine; Other: questionnaire administration; Procedure: assessment of therapy complications; Procedure: computed tomography; Procedure: quality-of-life assessment; Radiation: fludeoxyglucose F 18; Radiation: radiation therapy
Sponsors: Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2010
Conditions: HIV Infections; Hepatitis C; HCV Infection
Interventions: Drug: PEG2b plus ribavirin followed by placebo; Drug: PEG2b plus ribavirin followed by boceprevir/PEG2b/ribavirin
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Locally Advanced Rectal Cancer
Intervention: Procedure: Omission of surgery or transanal endoscopic microsurgery, combined with intensive follow-up
Sponsor: Maastricht University Medical Center
Recruiting - verified February 2010
Conditions: HIV Infection; HIV Infections
Interventions: Drug: raltegravir QD; Drug: atazanavir; Drug: lamivudine (or emtricitabine)
Sponsor: Radboud University
Recruiting - verified February 2010
Condition: Gonococcal Infections
Interventions: Drug: Azithromycin; Drug: Gentamicin; Drug: Gemifloxacin
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2010
Condition: Schizophrenia
Interventions: Drug: oral risperidone; Drug: paliperidone palmitate
Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC
Recruiting - verified February 2010
Condition: Prostate Cancer
Intervention: Drug: Cyproterone (Androcur, BAY94-8367)
Sponsor: Bayer
Recruiting - verified March 2010
Conditions: HIV; HIV Infections
Interventions: Drug: emtricitabine/tenofovir + lopinavir/ritonavir (WHO recommended second line); Drug: abacavir + didanosine + lopinavir/ritonavir (WHO recommended second line); Drug: emtricitabine/tenofovir + darunavir + ritonavir (Second line strategy under evaluation)
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; Gilead Sciences; Janssen Pharmaceutica N.V., Belgium
Recruiting - verified February 2010
Condition: Prostate Cancer
Intervention:
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: HIV Infections
Interventions: Drug: darunavir tablets; Drug: ritonavir capsule
Sponsors: Tibotec Pharmaceuticals, Ireland; Tibotec Pharmaceuticals
Recruiting - verified February 2010
Condition: HIV Infections
Interventions: Drug: 2 NRTI + 1 PI/r + Maraviroc + Raltegravir; Drug: 2 NRTI + 1 PI/r + Maraviroc + Raltegravir
Sponsors: MUC Research GmbH; Pfizer; Merck; Abbott
Recruiting - verified March 2010
Conditions: Impotence; Prostatic Neoplasms
Interventions: Drug: Sildenafil therapy plus post-NSRRP HBO2T; Drug: Sildenafil therapy plus sham post-NSRRP HBO2T
Sponsor: Hartford Hospital
Recruiting - verified March 2010
Condition: Erectile Dysfunction
Interventions: Drug: sildenafil citrate 100 mg CT; Drug: sildenafil citrate 100 mg CT; Drug: Viagra®
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Hypertension
Intervention: Other: Interactive Spaced Education (ISE) --- online education
Sponsor: Department of Veterans Affairs
Not yet recruiting - verified February 2010
Condition: Klinefelter Syndrome
Intervention:
Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting - verified March 2010
Condition: HIV Infections
Intervention: Drug: TMC207; nevirapine
Sponsor: Tibotec-Virco Virology BVBA
Recruiting - verified February 2010
Conditions: HIV Infections; Acquired Immunodeficiency Syndrome
Interventions: Drug: ATV/rtv 400/100mg; Drug: 48 weeks ATV/rtv 300/100mg once daily + ETR 200mg twice daily; Drug: ATV/rtv 300/100mg; Drug: TDF 300mg
Sponsor: Tibotec Pharmaceuticals, Ireland
Recruiting - verified February 2010
Condition: Fragile X Syndrome
Intervention: Drug: Riluzole
Sponsors: Indiana University; Indiana Clinical and Translational Science Institure (I-CTSI)
Recruiting - verified March 2010
Condition: Depression
Interventions: Other: Placebo; Drug: orvepitant
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Depression
Interventions: Drug: orvepitant; Other: placebo
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Cryptococcal Meningitis; HIV Infections
Interventions: Drug: Fluconazole; Drug: Amphotericin B
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Prostate Cancer
Intervention: Behavioral: QOL Questionnaire
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified March 2010
Conditions: Chronic Bronchitis; Disease Exacerbation
Intervention: Drug: Moxifloxacin (Avelox, BAY12-8039)
Sponsor: Bayer
Recruiting - verified March 2010
Conditions: Spontaneous Abortion; Malaria; Pregnancy Outcome; Stillbirth; HIV Infections
Intervention:
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Not yet recruiting - verified December 2009
Condition: Anterior Ischemic Optic Neuropathy
Intervention: Drug: Diagnostic procedures
Sponsor: Bayer
Recruiting - verified March 2010
Conditions: HIV Infections; Peripheral Neuropathy
Interventions: Drug: Duloxetine; Drug: Duloxetine placebo; Drug: Methadone; Drug: Methadone placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Conditions: HIV Infections; Tuberculosis
Intervention: Other: Standardized diagnostic evaluation
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Adult AIDS Clinical Trials Group; National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified June 2009
Condition: HIV Infections
Intervention:
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Conditions: HIV Infection; Herpesvirus 2, Human; HIV Infections
Interventions: Drug: valacyclovir; Drug: Placebo
Sponsor: University Health Network, Toronto
Recruiting - verified March 2010
Conditions: Obesity; Diabetes
Intervention: Behavioral: lifestyle intervention
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2010
Conditions: HIV; HIV Infections; Pregnancy
Interventions: Drug: TMC114 (darunavir); Drug: TMC125 (etravirine); Drug: TMC114r (ritonavir)
Sponsors: Tibotec, Inc; Tibotec Therapeutics, a Division of Centocor Ortho Biotech Services, L.L.C.
Recruiting - verified March 2010
Conditions: Acute HIV Infection; HIV Infections
Intervention: Drug: Darunavir/Ritonavir and Etravirine
Sponsors: The University of North Carolina, Chapel Hill; Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA
Recruiting - verified February 2010
Conditions: Herpes Zoster; HIV Infections
Interventions: Biological: Zoster Vaccine Live; Biological: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Adult AIDS Clinical Trials Group; Merck
Recruiting - verified May 2009
Conditions: HIV Infections; Treatment Naive
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Conditions: HIV; HIV Infections
Intervention: Behavioral: Video
Sponsors: North Bronx Healthcare Network; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified March 2010
Conditions: Low Testosterone Levels; Erectile Dysfunction
Interventions: Drug: Testim® + Viagra®; Drug: Placebo Testim® + Viagra®
Sponsor: Baylor College of Medicine
Recruiting - verified March 2010
Conditions: Human Immunodeficiency Virus Type 1 (HIV-1); HIV Infections
Interventions: Drug: Voriconazole; Drug: Atazanavir; Drug: Ritonavir; Drug: Voriconazole
Sponsor: Bristol-Myers Squibb
Recruiting - verified November 2009
Condition: Human Immunodeficiency Virus-1
Interventions: Drug: maraviroc; Drug: maraviroc
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Atopic Dermatitis
Interventions: Biological: ROUVAX; Biological: placebo
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Ministry of Health, France
Recruiting - verified March 2010
Condition: HIV Infections
Interventions: Biological: Vaccine; Biological: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Conditions: HIV Infections; Tuberculosis
Interventions: Drug: efavirenz; Drug: raltegravir; Drug: raltegravir
Sponsors: French National Agency for Research on AIDS and Viral Hepatitis; Gilead Sciences; Merck
Recruiting - verified February 2010
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate; Drug: Raltegravir; Drug: Darunavir; Drug: Ritonavir
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Bristol-Myers Squibb; Gilead Sciences; Merck; Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA
Recruiting - verified June 2009
Conditions: HIV Infections; Tuberculosis; Coinfection
Interventions: Drug: EFV and two NRTIs; Drug: Rifampin-containing anti-tuberculosis therapy
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified December 2008
Conditions: HIV Infections; HIV-1
Intervention: Drug: TMC278
Sponsor: Tibotec Pharmaceuticals, Ireland
Not yet recruiting - verified March 2010
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: Maraviroc
Sponsor: Pfizer
Recruiting - verified February 2010
Conditions: HIV Infection; HIV Seronegativity
Intervention:
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - verified March 2010
Condition: Systemic Lupus Erythematosus
Interventions: Other: Sugar Pill; Drug: N-acetylcysteine; Drug: N-acetylcysteine; Drug: N-acetylcysteine; Drug: N-acetylcysteine
Sponsor: State University of New York - Upstate Medical University
Recruiting - verified February 2010
Conditions: Hepatitis B; Human Immunodeficiency Virus; Hepatitis C, Chronic
Interventions: Drug: maraviroc; Drug: etravirine
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: HIV Infections
Intervention: Drug: Vicriviroc
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2009
Condition: HIV Infections
Interventions: Drug: Raltegravir and truvada; Drug: Atazanavir, Norvir and Truvada
Sponsors: The University of Texas Health Science Center, Houston; Merck
Recruiting - verified March 2010
Conditions: Bladder Cancer; Brain and Central Nervous System Tumors; Esophageal Cancer; Intraocular Melanoma; Kidney Cancer; Lymphoma; Melanoma (Skin); Pancreatic Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter
Interventions: Genetic: DNA analysis; Genetic: polymorphism analysis; Other: laboratory biomarker analysis; Other: questionnaire administration
Sponsor: Cancer Research UK
Recruiting - verified September 2008
Condition: Ovarian Cancer
Intervention: Biological: bevacizumab
Sponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: Colorectal Cancer
Interventions: Procedure: therapeutic conventional surgery; Procedure: therapeutic laparoscopic surgery
Sponsors: American College of Surgeons; National Cancer Institute (NCI)
Recruiting - verified March 2010
Conditions: Chronic Hepatitis C; Hepatitis C; HIV Infections
Interventions: Biological: PegIntron (peginterferon alfa-2b; SCH 54031) pen; Drug: Rebetol (ribavirin; SCH 18908)
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Genital Herpes
Intervention: Drug: acyclovir
Sponsors: University of Washington; National Institutes of Health (NIH)
Recruiting - verified March 2010
Conditions: Rectal Cancer; Rectum
Interventions: Behavioral: questionnaires; Behavioral: CSI-SH- Cancer Survivorship Intervention
Sponsors: Memorial Sloan-Kettering Cancer Center; Albert Einstein College of Medicine of Yeshiva University; Mount Sinai School of Medicine; M.D. Anderson Cancer Center; National Institutes of Health (NIH)
Recruiting - verified February 2010
Condition: Alcoholic Intoxication
Interventions: Drug: Alcohol; Procedure: Self-Administration
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified May 2009
Condition: HIV Infections
Intervention:
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: HIV Infections
Interventions: Drug: Highly Active Antiretroviral Therapy (HAART); Other: No treatment
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Conditions: End Stage Renal Disease; Sexual Dysfunction, Physiological; Pain; Depression
Interventions: Behavioral: Renal Symptom Management Nurse Practitioner Intervention; Behavioral: Feedback of Symptoms Intervention
Sponsors: Department of Veterans Affairs; Dialysis Clinics, Inc.; Liberty Dialysis; DaVita Dialysis
Recruiting - verified March 2010
Condition: HIV Infections
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Conditions: Aids-related Malignancies; Lymphoma; Precancerous Condition; Sarcoma
Interventions: Genetic: polymerase chain reaction; Other: cytology specimen collection procedure; Other: histological technique; Other: laboratory biomarker analysis; Procedure: colposcopic biopsy
Sponsors: AIDS Associated Malignancies Clinical Trials Consortium; National Cancer Institute (NCI)
Recruiting - verified March 2010
Conditions: Oropharyngeal Cancer; Head and Neck Cancer; Squamous Cell Carcinoma
Intervention: Behavioral: Questionnaire
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified March 2010
Condition: Human Immunodeficiency Virus
Interventions: Drug: Maraviroc along with an optimized background antiretroviral drug regimen; Drug: Optimized background antiretroviral drug regimen without maraviroc
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: HIV Infections
Interventions: Drug: Treatment initiation for HIV-1 group O infected patients; Drug: Treatment initiation for HIV-1 group M infected patients
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Not yet recruiting - verified February 2010
Conditions: HIV Infections; Tuberculosis
Interventions: Drug: rifabutin in combination with efavirenz; Drug: rifabutin in combination with nevirapine; Drug: rifabutin in combination with lopinavir/ritonavir
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Not yet recruiting - verified February 2010
Condition: Prostate Cancer
Interventions: Other: questionnaire administration; Procedure: quality-of-life assessment; Radiation: stereotactic radiosurgery
Sponsors: Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: Parkinson's Disease
Intervention: Drug: mantadix
Sponsor: University Hospital, Toulouse
Recruiting - verified February 2010
Condition: HIV Infections
Intervention: Biological: Ad26.ENVA.01 HIV-1 vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2008
Conditions: HIV Infections; Tuberculosis
Interventions: Drug: rifabutin in combination with efavirenz; Drug: rifabutin in combination with nevirapine; Drug: rifabutin in combination with lopinavir/ritonavir
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Recruiting - verified February 2010
Conditions: HIV Infections; Sexually Transmitted Diseases
Intervention: Biological: Quadrivalent human papillomavirus vaccine
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified June 2009
Condition: HIV Infections
Interventions: Drug: Enfuvirtide; Drug: Raltegravir; Drug: Darunavir; Drug: Tipranavir; Drug: Etravirine; Drug: Maraviroc
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Adult AIDS Clinical Trials Group
Recruiting - verified April 2009
Conditions: Genital Herpes; HIV Infections
Interventions: Drug: valacyclovir; Drug: acyclovir
Sponsors: University of Washington; GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Leukemia; Myelodysplastic Syndrome
Intervention: Behavioral: Interview
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: HIV Infections
Interventions: Procedure: Early Initiation of Highly Active Anti-Retroviral Therapy; Procedure: Standard Care
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Recruiting - verified February 2010
Condition: HIV Infections
Interventions: Drug: Raltegravir (MK-0518); Drug: Raltegravir (MK-0518); Drug: Raltegravir (MK-0518)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2009
Conditions: Cancer Survivor; Sexual Dysfunction and Infertility; Sexuality and Reproductive Issues; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Dietary Supplement: L-arginine/Korean ginseng/ Gingko biloba/damiana-based supplement; Other: placebo
Sponsors: Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified July 2009
Conditions: Amenorrhea; Hypogonadotropic Hypogonadism; Kallmann's Syndrome
Intervention: Procedure: Frequent baseline blood sampling
Sponsors: Massachusetts General Hospital; National Institutes of Health (NIH)
Recruiting - verified March 2010
Condition: HIV Infections
Interventions: Drug: AZT/3TC/NVP (zidovudine/lamivudine/nevirapine); Drug: d4T/3TC/NVP (stavudine/lamivudine/nevirapine); Drug: AZT/3TC/ABC (zidovudine/lamivudine/abacavir); Drug: d4T/3TC/ABC (stavudine/lamivudine/abacavir); Drug: ddl/ABC/LPV/r (didanosine/abacavir/lopinavir-ritonavir); Drug: AZT/3TC/ LPV/r (zidovudine/lamivudine/ lopinavir-ritonavir); Drug: - ABC/ddI or TDF/NVP or EFV (abacavir/didanosine or tenofovir/nevirapine or efavirenz); Drug: ABC/3TC/NVP (abacavir/lamivudine/nevirapine)
Sponsors: University of Washington; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified March 2010
Condition: HIV Infections
Intervention: Drug: maraviroc
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: HIV Infections; Pregnancy
Interventions: Drug: Maternal and infant nevirapine; Drug: Maternal placebo and infant nevirapine; Drug: Maternal lopinavir+ritonavir; Drug: zidovudine
Sponsors: Institut de Recherche pour le Developpement; Harvard School of Public Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2010
Condition: Benign Prostatic Hyperplasia (BPH)
Intervention: Device: Prolieve® Thermodilatation System
Sponsor: Boston Scientific Corporation
Recruiting - verified February 2010
Conditions: Leukemia; Long-term Effects Secondary to Cancer Therapy in Adults; Long-term Effects Secondary to Cancer Therapy in Children; Lymphoma; Sexual Dysfunction and Infertility; Sexuality and Reproductive Issues; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Other: laboratory biomarker analysis; Procedure: fertility assessment and management; Procedure: management of therapy complications; Procedure: ultrasound imaging
Sponsors: Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified February 2010
Condition: Urethritis
Interventions: Drug: Azithromycin; Drug: Doxycycline
Sponsors: University of Washington; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: HIV Infections
Intervention: Drug: Efavirenz (EFV) + Didanosine (ddI) + Emtricitabine (FTC)
Sponsor: Bristol-Myers Squibb
Recruiting - verified January 2010
Condition: Fragile X Syndrome
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified February 2010
Condition: Genital Herpes
Interventions: Drug: valacyclovir; Drug: valacyclovir
Sponsors: University of Washington; GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Kallmann's Syndrome; Hypogonadotropic Hypogonadism; Healthy Volunteers
Interventions: Drug: Letrozole; Drug: NAL-GLU GnRH antagonist; Drug: GnRH
Sponsors: Massachusetts General Hospital; National Institutes of Health (NIH)
Recruiting - verified March 2010
Condition: HIV
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified August 2009
Conditions: Healthy; Fragile X Syndrome
Intervention: Procedure: Follicle Aspiration
Sponsors: Massachusetts General Hospital; National Institutes of Health (NIH)
Recruiting - verified March 2010
Condition: HIV Infections
Interventions: Drug: carbamazepine and nevirapine; Drug: Nevirapine
Sponsor: Radboud University
Recruiting - verified February 2010
Condition: HIV Infections
Intervention: Behavioral: Community Mobilization
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified February 2010
Conditions: Excess Androgen; Congenital Adrenal Hyperplasia (CAH); Familial Male-Limited Precocious Puberty (FMPP)
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified June 2009
Condition: HIV Infections
Intervention: Procedure: blood draw
Sponsor: Rockefeller University
Recruiting - verified March 2010
Condition: HIV Infections
Intervention: Drug: Antiretroviral therapy
Sponsors: Rockefeller University; Aaron Diamond AIDS Research Center
Recruiting - verified March 2010
Condition: HIV Infection
Intervention: Drug: Efavirenz
Sponsor: Bristol-Myers Squibb
Available - verified January 2010
Condition: HIV Infection
Intervention: Drug: Efavirenz
Sponsor: Bristol-Myers Squibb
Available - verified January 2010
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cisplatin; Drug: cyclophosphamide; Drug: lomustine; Drug: vincristine sulfate; Radiation: radiation therapy
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2010
Conditions: Breast Cancer; Menopausal Symptoms; Sexual Dysfunction and Infertility
Interventions: Drug: cyclophosphamide; Drug: goserelin
Sponsors: Southwest Oncology Group; National Cancer Institute (NCI); Cancer and Leukemia Group B; Eastern Cooperative Oncology Group; International Breast Cancer Study Group
Recruiting - verified March 2010
Condition: Breast Cancer
Interventions: Drug: exemestane; Drug: tamoxifen citrate; Drug: triptorelin; Procedure: oophorectomy; Radiation: radiation therapy
Sponsors: International Breast Cancer Study Group; National Cancer Institute (NCI); Breast International Group; Cancer and Leukemia Group B; NCIC Clinical Trials Group; North Central Cancer Treatment Group; National Surgical Adjuvant Breast and Bowel Project (NSABP); Southwest Oncology Group
Recruiting - verified March 2010
Condition: HIV Infections
Intervention: Drug: Tipranavir
Sponsor: Boehringer Ingelheim Pharmaceuticals
Available - verified March 2010
Condition: HIV Infections
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Conditions: HIV Infection; Kaposi's Sarcoma
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified April 2009
Condition: Adrenal Gland Neoplasm
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified January 2010
Condition: Hepatitis C
Intervention:
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified February 2010
Condition: HIV Infections
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Conditions: Coronary Disease; Obesity
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2010
Conditions: Autoimmune Disease; Congenital Adrenal Hyperplasia; Healthy; Mental Disorder Diagnosed in Childhood; Neurologic Manifestations
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified November 2009
All Categories ... Medical Conditions » ... Sexual Disease 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
